SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME
申请人:Arbutus Biopharma Corporation
公开号:EP3893645A1
公开(公告)日:2021-10-20
[EN] SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME<br/>[FR] ARYLMÉTHYLURÉES ET HÉTÉROARYLMÉTHYLURÉES SUBSTITUÉES, ANALOGUES DE CES DERNIÈRES ET PROCÉDÉS D'UTILISATION DE CELLES-CI
申请人:ARBUTUS BIOPHARMA CORP
公开号:WO2020123674A1
公开(公告)日:2020-06-18
The present invention includes substituted arylmethyl ureas and heteroarylmethyl-ureas, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient.